This site is intended for healthcare professionals only
LoginRegister
Setback to Sun Pharma as Fibromun, Nidlegy Trials Miss Key Endpoints in Cancer StudiesSun Pharma net profit drops 20% to Rs 2,279 crore in Q1
Sandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in France for USD 300 millionSandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in...
Zydus Wellness sees senior leadership exitsZydus Wellness sees exit of Head-R&D, Head-GDSO
Natco Pharma appoints TC Mallikarjun as Vice President - QC at Kothur Pharma DivisionNatco Pharma appoints TC Mallikarjuna as Vice President - QC at Kothur Pharma Division
After Cough Syrup Deaths, IPC Issues Toolkit to Curb DEG, EG Contamination in Liquid FormulationsVeeda Clinical Research Gets Expert Committee Nod To Conduct BA/BE Study Of Ibrutinib For Export
Ajanta Pharma Sets Up Wholly Owned Subsidiary in IrelandAjanta Pharma Gets Relief in Erectile Dysfunction Drug Export Case, Penalty Set Aside
NPPA Panel Defers Biological Es Pneumonia Vaccine Price Exemption, Seeks ClarificationNPPA Panel Defers Biological E's Pneumonia Vaccine Price Exemption, Seeks Clarification
Aurobindo Pharma Gets 5 USFDA Observations for Unit-IV FacilityAurobindo Pharma Acquires Lannett for Rs 2,185 Cr to Boost U.S. Presence, ADHD Line
Pill form of Wegovy gets USFDA approval for weight lossNovo Nordisk Appoints Mike Doustdar as New CEO Amid Executive Reshuffle
Syngene International, Bristol Myers Squibb Extend Strategic Collaboration Through 2035CDSCO Panel Withholds Nod for Syngene's Pegfilgrastim Trial, Seeks Additional Data
Zydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study WaivedZydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study Waived
18 Medical Device Firms Got Rs 133.95 Cr in Incentives Till FY2024-25: Govt Tells RS18 Medical Device Firms Got Rs 133.95 Cr in Incentives Till FY2024-25: Govt Tells RS
X